Skip to content

'The Effect of Adding LFCN Block to PENG

The Effect of Adding Lateral Femoral Cutaneous Nerve Block to PENG Block on Postoperative Opioid Consumption in Hip Surgery

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06226675
Enrollment
60
Registered
2024-01-26
Start date
2023-01-01
Completion date
2024-04-01
Last updated
2024-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block, Opioid Consumption, Pain, Acute, Pain, Postoperative

Keywords

lateral femoral cutaneous nerve block, PENG block, Pain management, Opioid consumption

Brief summary

The incidence of femoral neck fracture in Europe is 330/10000 per year. It is increasing every year due to the aging of the population. In patients 55 years and older, hip fracture-related mortality is estimated to be between 4% and 16% at one month and between 11% and 43% at one year after surgery. The reduced risk of postoperative complications associated with the use of regional anesthesia, shorter mobilization times, and reduced morphine consumption in hip fractures have been reported, and have been incorporated into postoperative pain control as part of multimodal strategies. PENG has been described for postoperative pain control for surgery on the hip joint or for the treatment of post-traumatic pain associated with proximal femur/femoral head fractures. Lateral femoral cutaneous nerve block is used in combination with other peripheral block methods to provide analgesia in the lateral thigh. The investigators aimed to evaluate the effect of adding lateral femoral cutaneous nerve block to PENG block on pain scores and opioid consumption in femoral fracture procedures under spinal anesthesia.

Interventions

PROCEDUREPENG Block

To apply local anesthetic under psoas tendon

PROCEDURELFCN block

to apply local anesthetic around lateral femoral cutaneous nerve

Sponsors

Zonguldak Bulent Ecevit University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-75 years old, * ASA I-II-III risk group * patients undergoing hip fracture surgery under spinal anesthesia * Patients whose informed consent was read and consent was obtained from them and their representatives.

Exclusion criteria

* Those who do not want to participate in the study, * ASA IV-V patients * Those with coagulation disorders * Allergic to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
postoperative opioid consumptionup to 24 hour after surgerytotal morphine requirement

Secondary

MeasureTime frameDescription
pain scoresup to 24 hour after surgeryevaluating pain scores by Numeric Rating Score
first analgesic timeup to 24 hour after surgerythe need of first analgesic after surgery
postoperative complicationsup to 24 hour after surgerynausea-vomitting, motor block, hypertension, hypotension etc.
mobilization timeup to 24 hour after surgerywhen the patient is first mobilized

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026